Evidence map›Paper›PMID 26318370›Full record

ArticleEuropean radiology2016

Non-invasive MR assessment of macroscopic and microscopic vascular abnormalities in the rectal tumour-surrounding mesorectum.

Ewelina Kluza, Jean-Paul J E Kleijnen, Milou H Martens, Dorit Rennspiess, Monique Maas, Cécile R L P N Jeukens, Robert G Riedl, Axel zur Hausen, Geerard L Beets, Regina G H Beets-Tan

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ewelina KluzaDepartment of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ, Maastricht, Netherlands.
Jean-Paul J E KleijnenDepartment of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ, Maastricht, Netherlands.
Milou H MartensDepartment of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ, Maastricht, Netherlands.
Dorit RennspiessDepartment of Pathology, Maastricht University Medical Center, Maastricht, Netherlands.
Monique MaasDepartment of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ, Maastricht, Netherlands.
Cécile R L P N JeukensDepartment of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ, Maastricht, Netherlands.
Robert G RiedlDepartment of Pathology, Maastricht University Medical Center, Maastricht, Netherlands.
Axel zur HausenDepartment of Pathology, Maastricht University Medical Center, Maastricht, Netherlands.
Geerard L BeetsDepartment of Surgery, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Regina G H Beets-TanDepartment of Radiology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6202 AZ, Maastricht, Netherlands. beetstan@me.com.
Maastricht University · NLUniversity Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the MRI macroscopic and microscopic parameters of mesorectal vasculature in rectal cancer patients.

methodsThirteen patients with rectal adenocarcinoma underwent a dynamic contrast-enhanced MRI at 1.5 T using a blood pool agent at the primary staging. Mesorectal macrovascular features, i.e., the number of vascular branches, average diameter and length, were assessed from baseline-subtracted post-contrast images by two independent readers. Mesorectal microvascular function was investigated by means of area under the enhancement-time curve (AUC). Histopathology served as reference standard of the tumour response to CRT.

resultsThe average vessel branching in the mesorectum around the tumour and normal rectal wall was 8.2 ± 3.8 and 1.7 ± 1.3, respectively (reader1: p = 0.001, reader2: p = 0.002). Similarly, the tumour-surrounding mesorectum displayed circa tenfold elevated AUC (p = 0.01). Interestingly, patients with primary node involvement had a twofold higher number of macrovascular branches compared to those with healthy nodes (reader1: p = 0.005 and reader2: p = 0.03). A similar difference was observed between good and poor responders to CRT, whose tumour-surrounding mesorectum displayed 10.7 ± 3.4 and 5.6 ± 1.5 vessels, respectively (reader1/reader2: p = 0.02).

conclusionsWe showed at baseline MRI of rectal tumours a significantly enhanced macrovascular structure and microvascular function in rectal tumour-surrounding mesorectum, and the association of primary mesorectal macrovascular parameters with node involvement and therapy response. KEY POINTS: • Vascular MRI reveals macrovascular and microvascular abnormalities in the rectal tumour-surrounding mesorectum. • Formation of highly vascular stroma precedes the actual tumour invasion. • High macrovascular parameters are associated with node involvement. • Mesorectal vascular network differs for good and poor responders.

Indexed as

AdenocarcinomaAgedContrast MediaFemaleHumansImage EnhancementMagnetic Resonance ImagingMaleProspective StudiesRectal NeoplasmsRectumVascular MalformationsContrast MediaBlood pool imagingDynamic contrast-enhanced MRIMesorectal vasculatureNeoadjuvant chemoradiotherapyRectal cancer

Identifiers

PMID26318370
OpenAlexW1928815330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.